Launching the ARIA Genetics Medicines Frontier Hub

Prior to our work in the genomic therapeutics space, the Yu Lab’s research focused on the genetic foundations of autism. Now, these two interests have come together with the Genetic Medicines Hub in the Aligning Research to Impact Autism (ARIA) network.

This research hub — in collaboration with the University of Oxford, Jackson Laboratory, and N=1 Collaborative — will aim to catalyze the development of genetic medicines for neurodevelopmental disorders. Uniquely, this project will utilize novel technologies for therapeutic design, cell culture, and protein-level screening. Additionally, this project will support data sharing across multiple scientific and clinical contexts.

Ultimately, this project reflects longstanding goals of understanding the biological underpinnings of neurodevelopmental diagnoses, and improving availability, access, and equity for genetically targeted medicines.